Our work begins with a deep understanding of disease biology. We discover unprecedented insights about human disease through access to patient and genomic data. Once we identify the right target with a strong link to human disease, we turn to our R&D toolbox — a mix of traditional and cutting-edge modalities — to create the best compound for that specific target.
Our arsenal of therapeutic modalities continues to grow along with advances in innovation and knowledge. We invest in breakthrough platform technologies, AI/ML applications and drug delivery advances, helping us bring better medicines to patients faster.